PortalPublikationenIncidence and prognostic impact of ASXL2 mutations in adult ...

Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): A study of the German-Austrian AML study group (AMLSG)

Standard

Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): A study of the German-Austrian AML study group (AMLSG). / Jahn, N; Agrawal, M; Bullinger, L; Weber, D; Corbacioglu, A; Gaidzik, V I; Schmalbrock, L; Thol, F; Heuser, M; Krauter, J; Göhring, G; Kündgen, A; Fiedler, W; Wattad, M; Held, G; Köhne, C-H; Horst, H-A; Lübbert, M; Ganser, A; Schlenk, R F; Döhner, H; Döhner, K; Paschka, P.

in: LEUKEMIA, Jahrgang 31, Nr. 4, 04.2017, S. 1012-1015.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Jahn, N, Agrawal, M, Bullinger, L, Weber, D, Corbacioglu, A, Gaidzik, VI, Schmalbrock, L, Thol, F, Heuser, M, Krauter, J, Göhring, G, Kündgen, A, Fiedler, W, Wattad, M, Held, G, Köhne, C-H, Horst, H-A, Lübbert, M, Ganser, A, Schlenk, RF, Döhner, H, Döhner, K & Paschka, P 2017, 'Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): A study of the German-Austrian AML study group (AMLSG)', LEUKEMIA, Jg. 31, Nr. 4, S. 1012-1015. https://doi.org/10.1038/leu.2017.18

APA

Jahn, N., Agrawal, M., Bullinger, L., Weber, D., Corbacioglu, A., Gaidzik, V. I., Schmalbrock, L., Thol, F., Heuser, M., Krauter, J., Göhring, G., Kündgen, A., Fiedler, W., Wattad, M., Held, G., Köhne, C-H., Horst, H-A., Lübbert, M., Ganser, A., ... Paschka, P. (2017). Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): A study of the German-Austrian AML study group (AMLSG). LEUKEMIA, 31(4), 1012-1015. https://doi.org/10.1038/leu.2017.18

Vancouver

Jahn N, Agrawal M, Bullinger L, Weber D, Corbacioglu A, Gaidzik VI et al. Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): A study of the German-Austrian AML study group (AMLSG). LEUKEMIA. 2017 Apr;31(4):1012-1015. https://doi.org/10.1038/leu.2017.18

Bibtex

@article{eef2a5b7ad3f4e69bdf154be775316ee,
title = "Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): A study of the German-Austrian AML study group (AMLSG)",
abstract = "Leukemia accepted article preview online, 16 January 2017. doi:10.1038/leu.2017.18.",
author = "N Jahn and M Agrawal and L Bullinger and D Weber and A Corbacioglu and Gaidzik, {V I} and L Schmalbrock and F Thol and M Heuser and J Krauter and G G{\"o}hring and A K{\"u}ndgen and W Fiedler and M Wattad and G Held and C-H K{\"o}hne and H-A Horst and M L{\"u}bbert and A Ganser and Schlenk, {R F} and H D{\"o}hner and K D{\"o}hner and P Paschka",
note = "Letter",
year = "2017",
month = apr,
doi = "10.1038/leu.2017.18",
language = "English",
volume = "31",
pages = "1012--1015",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "4",

}

RIS

TY - JOUR

T1 - Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): A study of the German-Austrian AML study group (AMLSG)

AU - Jahn, N

AU - Agrawal, M

AU - Bullinger, L

AU - Weber, D

AU - Corbacioglu, A

AU - Gaidzik, V I

AU - Schmalbrock, L

AU - Thol, F

AU - Heuser, M

AU - Krauter, J

AU - Göhring, G

AU - Kündgen, A

AU - Fiedler, W

AU - Wattad, M

AU - Held, G

AU - Köhne, C-H

AU - Horst, H-A

AU - Lübbert, M

AU - Ganser, A

AU - Schlenk, R F

AU - Döhner, H

AU - Döhner, K

AU - Paschka, P

N1 - Letter

PY - 2017/4

Y1 - 2017/4

N2 - Leukemia accepted article preview online, 16 January 2017. doi:10.1038/leu.2017.18.

AB - Leukemia accepted article preview online, 16 January 2017. doi:10.1038/leu.2017.18.

U2 - 10.1038/leu.2017.18

DO - 10.1038/leu.2017.18

M3 - Other (editorial matter etc.)

C2 - 28090090

VL - 31

SP - 1012

EP - 1015

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 4

ER -